implications for treatment adherence, quality of life, and family functioning. Interventions have been developed to help parents cope with caring for young children with type 1 diabetes. [10] [11] [12] [13] [14] However, few of these psychosocial interventions have been focused on the adoption of advanced diabetes technology in very young children.
Diabetes technologies have improved substantially in the past several decades, with tools such as smart insulin pumps with bolus calculators and continuous glucose monitors (CGMs). Along with these technical advancements come new challenges and possible burdens, especially for young children and their families. For example, it can be difficult for parents to find "real estate" on their small children's bodies to attach and secure devices, and other caregivers need to be educated on these devices. 15, 16 Thus, it is important to ascertain typical burdens and stresses of parents of young children with diabetes in the contemporary diabetes management era. It is also important to understand how the burdens reported by parents are impacted by use or nonuse of different diabetes technologies, as well as by other demographic factors, such as socioeconomic status.
The aim of this study was to understand present-day burdens experienced by parents caring for their young child with type 1 diabetes. We investigated the burden reported by families with children in different age groups, toddlers (under 4 years), preschoolers (4-<6 years), and school age children (6-<7 years) to understand the unique burdens and family impacts at different developmental stages. Children in toddlerhood have limited verbal abilities which make it difficult to convey symptoms, preschool children are entering the school environment for the first time, and school age children and their parents need to establish new relationships with caregivers and rely on them more due to the longer days spent at school. All of these factors may have an impact on reported diabetes burdens. We anticipated that parents of young children with type 1 diabetes would report significant burdens and distress, highlighting the need to explore the factors related to burden and distress and ultimately identify approaches to overcome the challenges reported by parents of young children with type 1 diabetes, especially with potential burdens associated with advanced diabetes technologies.
Methods
The T1D Exchange Clinic Registry (T1D Exchange) includes 74 endocrinology practices based in the United States, including 58 centers serving youth with type 1 diabetes (see Supplemental Materials). To date, over 30 000 participants have been enrolled in the registry, and details of the enrollment process, eligibility criteria, and baseline data collection have been previously reported. 17 Data were collected for the clinic registry central database from medical records in addition to questionnaires completed by parents of the young children enrolled in the registry. 17 This report includes 597 young children enrolled in the registry since February 1, 2015, aged less than 7 years with a clinical diagnosis of type 1 diabetes for at least 1 year, whose parent/guardian completed the two surveys assessing the main constructs of interest in this study: parental burden and family impact (described below). Demographic, socioeconomic, and diabetes management factors were obtained from parent/guardian questionnaires. Insulin pump and CGM use were reported by parent/guardian and confirmed by clinic report. The most recent hemoglobin A1c (HbA1c) measurement within 6 months prior to registry enrollment (mean duration of HbA1c measurement prior to enrollment was 7 days) was obtained from the clinic medical record. HbA1c values were measured by point-of-care device or local laboratory. Occurrences of diabetic ketoacidosis (DKA) and severe hypoglycemia (SH) during the 3 months prior to enrollment were reported by parent/guardian. DKA was defined by occurrence of ketoacidosis diagnosed by a doctor requiring a visit to hospital, emergency room, or other health care facility. SH was defined as hypoglycemia resulting in seizure or loss of consciousness.
The Problem Areas in Diabetes Survey-Parent Revised version (PAID-PR) 18 measures the degree of burden experienced by the parents while managing their child with type 1 diabetes. Parents/guardians were asked to rate their agreement with 18 statements regarding the burden of diabetesrelated issues using a 0 (agree) to 4 (disagree) Likert-type scale. Total score for each participant was the mean of all nonmissing responses reversed scored then multiplied by 25 for a total possible score of 100, with higher scores representing higher parental burden.
The Family Impact Survey (FIS) 19 measures a different kind of burden, how often diabetes impacted family life in the past year. Parents were asked to rate how often diabetes negatively affected areas such as school, work, finances, and well-being using a 0 (almost never) to 3 (almost always) Likert-type scale, which was scored for each participant as the mean of all nonmissing responses multiplied by 33.3 for a total score out of 100. Higher FIS scores represent more negative impact of diabetes on the family. Parents had the option of selecting "not applicable" for any of the responses on the FIS. These values were excluded from tabulations and calculations of the total score.
Statistical Analyses
For both the PAID-PR and FIS, the mean total score was tabulated according to various demographic and clinical characteristics. The amount of burden and the degree of negative family impact for the individual responses to the PAID-PR and FIS surveys were tabulated overall and according to age group (<4, 4-<6, and 6-<7 years), with presentation of percentages of the sample endorsing various burdens or family impacts. The associations between each mean total score and demographic and clinical characteristics were assessed overall and according to age group (<4, 4-<6, and 6-<7 years) using t-tests or the Wilcoxon Rank-Sum procedure (or Kruskal-Wallis if >2 levels) as appropriate. An unadjusted linear regression model was used to determine the association with HbA1c. Data analyses were performed using SAS version 9.4 (2011 SAS Institute Inc, Cary, NC). All P values are two-sided, and due to multiple comparisons only P values <.01 were considered statistically significant.
Results

Participant Characteristics
The mean age of the 597 children was 5.2 ± 1.2 years (n = 111 <4 years, n = 291 4-<6 years, and n = 195 6-<7 years) and mean duration of diabetes was 2.4 ± 1.1 years. Mean HbA1c was 8.2% ± 1.1%. Approximately one-third (31%) were identified as current CGM users and more than half (58%) were using insulin pumps. Additional cohort characteristics are shown in Table 1 .
Survey Tabulations
Figures 1 and 2 show the areas in which parents feel most burdened by or experience high negative family impact from their young child's diabetes for each age group. Overall, most parents reported the largest burden of diabetes related to worrying about their child having a low blood sugar (74%). Other areas in which parents felt most burdened by diabetes involved worrying about the future and the possibility of serious complications for their child (70%), feeling upset when their child's diabetes management is "off track" (61%), worrying that their child will not be taken care of when away from home (57%), and feeling upset when their child's blood sugars are out of range (54%). Parents felt least burdened about their child being excluded from activities/ events because of diabetes (13%), having difficulty dealing with school staff (12%), their child being deprived regarding food and meals (11%), and feeling discouraged with their child's diabetes treatment plan (5%).
Areas in which parents experienced frequent negative family impact were diminished amount or quality of sleep for family members (59%) and the need for flexible working arrangements to help care for their child (55%). Problems with regular school attendance (7%), negative impact of diabetes on school performance (5%), and the inability to participate in activities or trips (5%) were the areas in which parents reported the lowest impact on their family life.
Parental Burden Results
The mean total PAID score was 45.7 ± 18.9 overall, 46.9 ± 18.6 for parents of children <4 years, 47.0 ± 18.6 for parents of children 4-<6 years, and 43.2 ± 19.4 for parents of children Occurrence of at least one severe hypoglycemia (SH) event in the past 3 months resulting in seizure or loss of consciousness, and occurrence of at least one diabetic ketoacidosis (DKA) event in the past 3 months.
aged 6-<7 years (P = .12, Table 2a ). The mean total PAID score was not significantly different between parents of females and parents of males (45.2 ± 17.8 vs 46.2 ± 19.9 for females and males, respectively; P = .50), but when stratified by age group, there was a trend toward lower PAID scores in parents of female toddlers compared with parents of male toddlers (42.7 ± 17.8 vs 50.5 ± 18.6, P = .05; Table 2a ).
Overall, there was a trend toward higher PAID scores in parents with less education and earning less than $75,000 annually (P = .07 and P = .05, respectively), but this trend was not seen when stratified by age group (Table 2a) . A higher PAID score was seen among parents of non-white children overall and in the 6-<7-year age group (p<0.01 for both).
Mean total PAID scores did not differ among parents of participants using a pump versus injections for insulin delivery (P = .87) or among CGM users versus nonusers (P = .82) when assessed for the overall cohort or when stratified by age group. No significant difference in mean PAID scores was seen among parents of children achieving glycemic target of HbA1c <7.5% versus HbA1c ≥7.5% (43.9 ± 17.6 vs 46.5 ± 19.3, P = .51), or who had at least one SH event versus no event (47.5 ± 24.3 vs 45.6 ± 18.5, P = .41). A trend toward higher PAID scores was seen in parents of participants who had at least one DKA event versus no event (52.0 ± 19.7 vs 45.4 ± 18.8, P = .06). Results were similar when stratified by age group.
Family Impact Results
The mean total FIS score was 27.2 ± 19.2 overall, 29.9 ± 19.8 for parents of children <4 years, 28.0 ± 20.5 for parents of children 4-<6 years, and 24.4 ± 16.4 for parents of children aged 6-<7 years (P = .10, Table 2b ). The mean total FIS score was not significantly different between parents of females and parents of males (26.0 ± 17.6 vs 28.2 ± 20.5 for females and males, respectively; P = .41, Table 2b ). A trend toward higher family impact of diabetes among households earning <$75,000 annually was seen overall (P = .09) and in the 6-<7-year age group (P = .06) (Table  2b ). No differences were seen with regards to race/ethnicity or parental education.
There was a trend toward higher total FIS score among both parents of children using a CGM compared to non-CGM users (29.3 ± 18.3 vs 26.2 ± 19.6, P = .01) and among parents of children using a pump compared to multiple daily injections (28.2 ± 18.8 vs 25.3 ± 19.1, P = .03). The trend toward higher FIS scores among parents of pump users was also seen in the <4 year and 6-<7-year age groups (P = .03 and .05, respectively).
No significant difference in mean FIS scores was seen among parents of children achieving glycemic target HbA1c of <7.5% versus HbA1c ≥7.5% (27.5 ± 18.9 vs 27.0 ± 19.3, P = .24), who had at least one SH event versus no event (34.9 ± 28.6 vs 26.6 ± 18.2, P = .21), or who had at least one DKA event versus no event (34.5 ± 24.9 vs 26.8 ± 18.8, P = .14). Results were similar when stratified by age group. Comparison of total score according to diabetes duration was not completed for the <4-year age group due to small sample size. b Categories are for display purposes only; the P value is from analyzing as continuous. The number of participants with events was too small to perform analyses stratified by age. d Occurrence of at least one severe hypoglycemia (SH) event in the past 3 months resulting in seizure or loss of consciousness, and occurrence of at least one diabetic ketoacidosis (DKA) event in the past 3 months.
Conclusions
Data for this study were collected from the largest published national (United States) sample of young children under age 7 using previously validated surveys, and the sample was drawn from multiple diabetes treatment centers in geographically diverse areas, which contribute to both the validity and the generalizability of the results. Parents endorsed substantial burdens relating to hypoglycemia, managing blood sugars, and potential complications of poor diabetes management. Notably, only 5% of parents reported feeling discouraged about their child's diabetes treatment plan, suggesting adequate support from their multidisciplinary treatment teams. In terms of family impact, parents reported sleep issues and the need for flexible work arrangements as significant factors. The age span of 3-<7 encompasses many dynamic changes and developmental stages and so it was originally thought burden may be different in each age group, however, our results suggest there is no significant difference in terms of type and frequency of burden between the age periods of toddler, preschoolers, and school aged children. The most common concern endorsed by parents of young children with diabetes was fear of their child having a low blood glucose, which is supported by findings in previous literature. Categories are for display purposes only; the P value is from analyzing as continuous. The number of participants with events was too small to perform analyses stratified by age. d Occurrence of at least one severe hypoglycemia (SH) event in the past 3 months resulting in seizure or loss of consciousness, and occurrence of at least one diabetic ketoacidosis (DKA) event in the past 3 months.
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It is important to recognize this as a very common concern in families of young children with type 1 diabetes, as parents may direct their child's diabetes management toward hyperglycemia to reduce risk for hypoglycemia. For example, this worry may impact the behavior of parents of young children, who may reduce insulin doses to alleviate fears of a hypoglycemic event.
Thus, providers can address such parental worries in efforts to achieve target glycemic control. Parents also expressed concerns about the long-term impact of type 1 diabetes for their children, with 70% endorsing worry about potential long-term complications. Thus, parents seem to worry about both hypoglycemia and hyperglycemia, feel upset when numbers are "off track" or out of range, and worry that their child will not be taken care of when the child is not in their care. If a vast majority of parents are worried about both the short-and long-term risks of diabetes, any indication that the child is not in range may cause worry and add to diabetes burden. These parents recognize they are responsible for their child's diabetes care and that, coupled with knowledge of the implications of out of range blood glucose values, can make taking care of diabetes in their young child an arduous task.
Sleep interference was also endorsed in these surveys and has been a consistent theme in the literature. [21] [22] [23] [24] The sleep quality of both parents and children can be compromised due to the need for diabetes care overnight. Parents who use CGM or remote monitoring technology may check glucose levels on devices frequently. This type of technology may help manage parental fear of hypoglycemia, but may lead to disruption of sleep to check a glucose value and give a corrective dose or low glucose treatment as needed.
There were two demographic findings for both diabetes burden and family impact. Higher parental burden was reported among parents of children who are non-white. Minority families may be under additional stress, which may increase diabetes burden. 25 There was also a trend toward higher parental burden among parents with lower education, and a trend toward both higher parental burden and negative family impact among families with lower incomes. Diabetes burden may have a greater impact on families with fewer resources. For example, parents who have less income may experience financial stress due to missed work time and additional medical expenses.
The FIS suggested that families who use insulin pumps and CGMs experience more negative impact from their child's diabetes. However, given the cross-sectional nature of these data, we cannot determine causality. In other words, we cannot determine whether families for whom diabetes has a greater negative family impact turn to technology to alleviate the burden, or if wearing advanced diabetes technology devices creates more burden. Future longitudinal research can help assess these associations.
There are a few limitations to consider when interpreting the results of this study. First, this was a cross sectional study; thus no causal inferences can be drawn from the results. Second, surveys were self-reported. It is possible that parents who enrolled their child in the registry and completed the entry survey differ in their degree of diabetes-related burden or family impact from parents who chose not to enroll or complete the survey. Further studies using multiple methods of reporting such as survey and qualitative methodology may help to clarify findings with numerous possible interpretations. Third, we chose to conduct the analysis in three different age groups due to the diversity in developmental skills observed across this young age range. A major goal of this study was to understand parents' perceptions of burden, and subgrouping the analysis helped us to accomplish this goal. However, the subgroups contained relatively small numbers of respondents; therefore, detecting statistical significance within the different subgroups becomes more challenging. Finally, advanced diabetes technologies are evolving at a rapid pace. During the course of our data collection there was a significant evolution in CGM technology with the advent of remote monitoring and connectivity to cell phones in 2015. There may be variability in the results in terms of parental burden and family impact due to some parents having access to newer technology. Indeed, the generalizability of these results will continue to be challenged due to the rapid evolution of technology.
This investigation highlights that all families of young children with diabetes experience diabetes related burden and report that diabetes has impact on their family life. Behavioral interventions need to be developed and available to all families that focus on helping the parents of young children understand how usual developmental challenges at different stages impact diabetes management of a young child. Intervention components need to provide strategies, skills, and support integrated into routine care to support parental quality of life related to diabetes management. These interventions must also provide guidance to parents implementing advanced diabetes treatments and technologies. Such interventions may have a positive impact on parents and ultimately on diabetes outcomes for young children with type 1 diabetes.
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